+ Site Statistics
References:
52,654,530
Abstracts:
29,560,856
PMIDs:
28,072,755
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn

+ Translate
+ Recently Requested

Recurrent thromboembolic and stroke risk in patients with neurological events and antiphospholipid antibodies



Recurrent thromboembolic and stroke risk in patients with neurological events and antiphospholipid antibodies



Annals of Neurology 28(2): 226




(PDF emailed within 1 workday: $29.90)

Accession: 033120512

Download citation: RISBibTeXText



Related references

Risk of recurrent thromboembolic events in patients with focal cerebral ischemia and antiphospholipid antibodies. The Antiphospholipid Antibodies in Stroke Study Group. Stroke 23(2 Suppl): I29-I32, 1992

Risk of recurrent thromboembolic events in patients with focal cerebral ischemia and antiphospholipid antibodies. Stroke 23(2 SUPPL 1): I29-I32, 1992

Anticardiolipin antibodies and the risk of recurrent thrombo-occlusive events and death. The Antiphospholipid Antibodies and Stroke Study Group (APASS). Neurology 48(1): 91-94, 1997

Antiphospholipid antibodies and recurrent thrombo-occlusive events The Antiphospholipid Antibodies and Stroke Study. Neurology 58(7 Supplement 3): A257-A258, April 9, 2002

Prospective longitudinal study of antiphospholipid antibodies in patients with primary antiphospholipid antibody syndrome-correlation with thromboembolic events, treatment and outcome. Arthritis & Rheumatism 36(9 SUPPL ): S243, 1993

Recurrent miscarriage, antiphospholipid antibodies and the risk of thromboembolic disease. Clinical Reviews in Allergy and Immunology 43(3): 265-274, 2013

Antiphospholipid antibodies and the risk of thromboembolic events in valvular heart disease. Mayo Clinic Proceedings 78(3): 294-298, 2003

Risk of thromboembolic events after recurrent spontaneous abortion in antiphospholipid syndrome: a case-control study. Annals of the Rheumatic Diseases 71(1): 61-66, 2012

Recommended Therapeutic INR Range for Patients with Antiphospholipid Syndrome on Warfarin Anticoagulation: Is Moderate-Intensity (INR 2.0 - 3.0) or High-Intensity (INR 3.1 - 4.0) Better for Reducing Risk of Recurrent Thromboembolic Events?. Cureus 8(9): E765, 2016

Reduced plasma fibrin clot permeability is associated with recurrent thromboembolic events in patients with antiphospholipid syndrome. Rheumatology 57(8): 1340-1349, 2018

Antiphospholipid antibodies and risk for recurrent vascular events. JAMA 291(22): 2701; Author Reply 2702-3, 2004

Antiphospholipid antibodies and risk for recurrent vascular events. JAMA 291(22): 2701-2; Author Reply 2702-3, 2004

Do patients with systemic lupus erythematosus and antiphospholipid syndrome have anti-beta-2 glycoprotein-I antibodies before the thrombotic/neurological events? Analysis of sequential samples from patients with clinical events during the follow-up. British Journal of Rheumatology 36(SUPPL 1): 18, 1997

Recurrent thromboembolic events after ischemic stroke in patients with cancer. Neurology 83(1): 26-33, 2014

The relationship of antiphospholipid antibodies to thromboembolic events in pediatric patients with systemic lupus erythematosus: a cross-sectional study. Pediatric Research 44(3): 351-356, 1998